Acute Lymphoblastic Leukemia
📧 Sign up to get email alerts when something new happens for Acute Lymphoblastic Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-07-10Clinical Trial Update: Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Relapsed Acute Lymphocytic Leukemia [Phase 2]
A Phase 2 trial evaluating combination chemotherapy followed by peripheral stem cell transplantation in children with relapsed acute lymphob…
-
CLINICAL_TRIALS research · 2013-07-10Clinical Trial Update: Studying Genes in Samples From Younger Patients With Acute Lymphoblastic Leukemia
A clinical trial update is investigating genes in samples from younger patients with acute lymphoblastic leukemia. The sponsor is the Easter…
-
CLINICAL_TRIALS trial_result · 2013-07-02Clinical Trial Update: A Phase 1 Dose Escalation Study of TAK-901 in Subjects With Advanced Hematologic Malignancies [Phase 1]
A Phase 1 dose-escalation study of TAK-901 in subjects with advanced hematologic malignancies; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-28Clinical Trial Update: Pharmacokinetic Study of Doxorubicin in Children With Cancer [Phase 2]
A completed Phase 2 pharmacokinetic study of doxorubicin in pediatric cancer patients, providing pharmacokinetic data for children with Wilm…
-
CLINICAL_TRIALS trial_result · 2013-06-26Clinical Trial Update: Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation or Isotretinoin in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Acute Lymphocytic Leukemia [Phase 1, Phase 2]
A Phase 1/2 clinical trial comparing combination chemotherapy followed by peripheral stem cell transplantation versus isotretinoin in patien…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-06-26Clinical Trial Update: The Influence of Thiopurine Methyltransferase Activity on Toxicity After High-dose Methotrexate in Childhood Acute Lymphoblastic Leukemia
The study investigates whether thiopurine methyltransferase (TPMT) activity affects toxicity from high-dose methotrexate in pediatric acute …
-
CLINICAL_TRIALS trial_result · 2013-06-21Clinical Trial Update: Arsenic Trioxide in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia [Phase 2]
A Phase 2 trial evaluating arsenic trioxide for relapsed or refractory acute lymphoblastic leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-20Clinical Trial Update: Combination Chemotherapy in Treating Patients With Acute B-Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma [Phase 2]
A Phase 2 clinical trial evaluating combination chemotherapy in patients with acute lymphoblastic leukemia or non-Hodgkin lymphoma. The stud…
-
FDA approval · 2013-06-17FDA Approved: CYCLOPHOSPHAMIDE — Supplemental Application (Civica, Inc.)
FDA approved a supplemental application for cyclophosphamide from Civica, Inc. under ANDA 040745.
-
CLINICAL_TRIALS research · 2013-06-13Clinical Trial Update: Study of Metabolic Syndrome in Young Patients Who Are Acute Lymphoblastic Leukemia Survivors and Their Healthy Siblings
This completed clinical trial evaluated metabolic syndrome in young survivors of acute lymphoblastic leukemia and their healthy siblings, sp…
-
CLINICAL_TRIALS trial_result · 2013-06-12Clinical Trial Update: Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic Leukemia [Phase 3]
A Phase 3 trial comparing chemotherapy with or without bone marrow transplantation in patients with acute lymphoblastic leukemia has complet…
-
CLINICAL_TRIALS withdrawal · 2013-06-12Clinical Trial Update: Acupuncture Point Stimulation for Treatment of Chemotherapy Nausea and Vomiting [NA]
A pediatric clinical trial evaluating acupuncture point stimulation to prevent chemotherapy-induced nausea and vomiting has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2013-06-06Clinical Trial Update: Rituximab Plus Interleukin-2 in Treating Patients With Hematologic Cancer [Phase 1]
Phase 1 trial evaluating rituximab in combination with interleukin-2 in various hematologic cancers has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-06Clinical Trial Update: Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia or Advanced Lymphoblastic Non-Hodgkin's Lymphoma [Phase 3]
A Phase 3 trial evaluating a combination chemotherapy regimen for pediatric patients with acute lymphoblastic leukemia or advanced lymphobla…
-
CLINICAL_TRIALS trial_result · 2013-06-05Clinical Trial Update: Alemtuzumab With or Without Methotrexate and Mercaptopurine in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia [Phase 2]
Phase 2 clinical trial evaluating alemtuzumab with or without methotrexate and mercaptopurine for relapsed acute lymphoblastic leukemia in y…
-
CLINICAL_TRIALS trial_result · 2013-06-05Clinical Trial Update: 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Young Patients With Relapsed or Refractory Solid Tumors or Leukemia [Phase 1]
Phase 1 clinical trial evaluating safety and dosing of 17-N-allylamino-17-demethoxygeldanamycin (tanespimycin) in pediatric patients with re…
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Tanespimycin in Treating Young Patients With Recurrent or Refractory Leukemia or Solid Tumors [Phase 1]
Completed Phase 1 trial evaluating tanespimycin in pediatric patients with recurrent or refractory leukemia or solid tumors.
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: 17-N-Allylamino-17-Demethoxygeldanamycin and Bortezomib in Treating Patients With Relapsed or Refractory Hematologic Cancer [Phase 1]
Phase 1 clinical trial evaluating the combination of tanespimycin (17-allylamino-17-demethoxygeldanamycin) and bortezomib in relapsed or ref…
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Flavopiridol in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia [Phase 1]
A Phase 1 clinical trial of flavopiridol (alvocidib) in relapsed or refractory acute myeloid leukemia, acute lymphoblastic leukemia, or chro…
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Monoclonal Antibody Therapy in Treating Patients With Chronic Lymphocytic Leukemia, Lymphocytic Lymphoma, Acute Lymphoblastic Leukemia, or Acute Myeloid Leukemia [Phase 1]
Phase 1 clinical trial of a monoclonal antibody therapy in patients with chronic lymphocytic leukemia, small lymphocytic lymphoma, acute lym…
-
CLINICAL_TRIALS trial_result · 2013-05-29Clinical Trial Update: Combination Chemotherapy Based on Risk of Relapse in Treating Young Patients With Acute Lymphoblastic Leukemia [Phase 3]
Phase 3 trial evaluating risk-adapted combination chemotherapy for young patients with acute lymphoblastic leukemia has completed.
-
CLINICAL_TRIALS withdrawal · 2013-05-20Clinical Trial Update: Trial of Oncaspar® and Three Doses of Pegylated Recombinant Asparaginase in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukaemia [Phase 1, Phase 2]
A Phase 1/2 trial evaluating Oncaspar and three doses of pegylated recombinant asparaginase in adults with newly diagnosed acute lymphoblast…
-
FDA approval · 2013-05-17FDA Approved: TASIGNA — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for TASIGNA (nilotinib) submitted by Novartis Pharmaceuticals Corporation.
-
FDA approval · 2013-05-14FDA Approved: MERCAPTOPURINE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for mercaptopurine from Mylan Pharmaceuticals Inc., authorizing a generic version under an appro…
-
CLINICAL_TRIALS trial_result · 2013-05-03Clinical Trial Update: Vorinostat, Cytarabine, and Etoposide in Treating Patients With Relapsed and/or Refractory Acute Leukemia or Myelodysplastic Syndromes or Myeloproliferative Disorders [Phase 1]
Phase 1 study evaluating a combination of vorinostat, cytarabine, and etoposide in patients with relapsed or refractory acute leukemia, myel…